首页> 外文会议>International Conference on Advances in Natural and Applied Sciences >The Molecular Mechanism for Interaction of Ceruloplasmin and Myeloperoxidase
【24h】

The Molecular Mechanism for Interaction of Ceruloplasmin and Myeloperoxidase

机译:岩浆纤维素和髓氧化酶相互作用的分子机制

获取原文

摘要

Ceruloplasmin (Cp) is a copper-containing ferroxidase with potent antioxidant activity. Cp is expressed by hepatocytes and activated macrophages and has been known as physiologic inhibitor of myeloperoxidase (MPO). Enzymatic activity of MPO produces anti-microbial agents and strong prooxidants such as hypochlorous acid and has a potential to damage host tissue at the sites of inflammation and infection. Thus Cp-MPO interaction and inhibition of MPO has previously been suggested as an important control mechanism of excessive MPO activity. Our aim in this study was to identify minimal Cp domain or peptide that interacts with MPO. We first confirmed Cp-MPO interaction by ELISA and surface plasmon resonance (SPR). SPR analysis of the interaction yielded 30 nM affinity between Cp and MPO. We then designed and synthesized 87 overlapping peptides spanning the entire amino acid sequence of Cp. Each of the peptides was tested whether it binds to MPO by direct binding ELISA. Two of the 87 peptides, P18 and P76 strongly interacted with MPO. Amino acid sequence analysis of identified peptides revealed high sequence and structural homology between them. Further structural analysis of Cp's crystal structure by PyMOL software unfolded that both peptides represent surface-exposed sites of Cp and face nearly the same direction. To confirm our finding we raised anti-P18 antisera in rabbit and demonstrated that this antisera disrupts Cp-MPO binding and rescues MPO activity. Collectively, our results confirm Cp-MPO interaction and identify two nearly identical sites on Cp that specifically bind MPO. We propose that inhibition of MPO by Cp requires two nearly identical sites on Cp to bind homodimeric MPO simultaneously and at an angle of at least 120 degrees, which, in turn, exerts tension on MPO and results in conformational change.
机译:血浆铜蓝蛋白(CP)是具有强效的抗氧化活性的含铜ferroxidase。 Cp由肝细胞和激活的巨噬细胞表达,并已被称为髓过氧化物酶的生理抑制剂(MPO)。 MPO酶的酶活性产生的抗微生物剂和强prooxidants如次氯酸和具有炎症和感染的位点的潜在损坏宿主组织。因此的Cp-MPO相互作用和MPO的抑制先前已建议作为过度MPO活性的一个重要的控制机制。我们在这项研究的目的是确定最小的Cp域或肽相互作用与MPO。我们首先证实了ELISA和表面等离子体共振(SPR)的Cp MPO互动。相互作用的SPR分析产生Cp和MPO之间30nM的亲和力。然后,我们设计并合成了87种重叠肽覆盖了整个氨基酸Cp的氨基酸序列。每种肽进行了测试是否通过直接结合ELISA结合MPO。 87种肽的二,P18和P76与MPO强相互作用。鉴定的肽的氨基酸序列分析揭示高的序列以及它们之间的结构同源性。通过PyMOL的软件的Cp晶体结构的进一步的结构分析展开,这两个肽代表几乎相同的方向Cp的表面暴露位点和面部。为了证实我们的发现,我们提出在兔抗P18抗血清和证明这种抗血清破坏的Cp MPO结合和救援MPO活性。总的来说,我们的研究结果证实的Cp MPO互动和鉴定特异性结合MPO Cp上两个几乎相同的网站。我们提出通过的Cp MPO的抑制需要Cp上两个几乎相同的位点以同时并且在至少120度,这反过来,施加在构象变化对MPO张力和结果的角度结合的同型二聚体MPO。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号